Despite the protests of Novartis Pharmaceuticals Corp., a federal district judge has granted the request of two plaintiffs to remand their case to state court, sending the suit back to the lower court as the product liability litigation over bone cancer drugs Aredia and Zometa continues to unfold.
The families of airplane passengers who were killed in the Sept. 11, 2001 terrorist attacks have once again asked the federal court to release a cockpit voice recording that chronicled the last 30 minutes on United Airlines flight 93.
Celgene Corp. has filed another patent suit against Barr Pharmaceuticals Inc. in an attempt to stave off generic competition for its lucrative cancer treatment Thalomid, which brought in $117.7 million in net sales in the second quarter of 2007.
Unwilling to accept defeat, Appaloosa Management LP has submitted its statement of the issues to be presented to the Manhattan district court as the hedge fund appeals the New York bankruptcy court's recent decision to endorse Dana Corp's financing agreement with an outside investment firm.
Verizon Wireless Services LLC has been slapped with a proposed class action claiming that the cellular telephone company charges users for simply logging on to AOL Instant Messenger, contrary to the promises it reportedly set out in news releases.
After months of back and forth, The New York State Public Service Commission has unanimously approved the $7.3 billion merger of KeySpan Corp. and British power giant National Grid PLC, removing one of the last remaining obstacles to the buyout deal.
The Judicial Panel on Multidistrict Litigation has refused a request to centralize three cases filed against Pfizer, Inc. over its birth control product Depo-Provera, handing drug giant Pfizer a victory in the transfer dispute.
Novartis Pharmaceuticals Corp. has objected to a magistrate judge's recommendation that the court grant a bid by two plaintiffs in the Aredia and Zometa litigation to remand their cases to state court, arguing that the court should maintain jurisdiction in order to protect the “substantial federal interests at stake” in the case.
A trio of patent infringement lawsuits involving Schering-Plough Corp.'s allergy medication Clarinex has been consolidated by the judicial panel on multidistrict litigation and sent to the U.S. District Court for the District of New Jersey.
MedPointe Healthcare Inc. on Wednesday filed a patent infringement suit against Cobalt Pharmaceuticals Inc. in an attempt to stop the Canadian drug company from making a generic version of its anti-allergy medication.
Amid mounting concern over product safety standards for Chinese imports, retail behemoth Wal-Mart revealed Wednesday that it had pulled two brands of dog treats from shelves last month because they showed traces of melamine, a toxic chemical used in plastics and fertilizer.
A dispute between the Port Authority of New York and New Jersey and several insurance companies over liability for the destruction of the World Trade Center continued Friday, with each side strongly opposing the other's motions for summary judgment.
Consolidated Energy Co. of New York Inc. and its insurers have asked for more time to add claims for indemnity to their complaint over property damage at 7 World Trade Center after the Sept. 11, 2001 attacks.
Becton Dickinson & Co. on Friday slammed three suits that accused it of stifling competition from other hypodermic product makers, denying that it has done anything wrong and averring that the plaintiffs—among them wholesalers, pharmacies, and hospitals—had no standing to sue.
A federal judge overseeing the multidistrict litigation against Eli Lilly & Co.'s blockbuster Zyprexa has adopted the recommendations of the special master in the case, who proposed a fund for the lawyers of plaintiffs who opted out of the November 2005 deal with the drug maker.
Four former Tyco International Ltd. directors have asserted that the Supreme Court's Tellabs decision mandates dismissal of several of a group of New Jersey plaintiffs' securities claims, which a judge failed to dismiss a mere ten days before Tellabs was decided.
A U.S. judge has kept alive a bid by Canadian investment bank CIBC World Markets Inc. for $13 million in default damages in a securities fraud case against Deustche Bank, ignoring the recommendations of a fellow judge to deny the claim.
Optimistic that the unions and Dana will stick to their new pact, attorneys for two labor organizations have asked a judge to temporarily suspend an earlier appeal, triggered by the bankruptcy court's decision to sign off on the supplier's bid to modify its employment agreements.
Two additional cases have been transferred to the Human Tissue multidistrict litigation this week, joining almost 200 suits that allege patients became vulnerable to HIV and other infectious diseases after having the blood tissue of cadavers inserted during medical procedures.
Telecommunications providers Verizon and Sprint have been awarded $1 million by a Manhattan judge, ending a dispute over insurance for damaged underground cables.